Compounds > alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
Page last updated: 2024-10-21

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Smoking Cessation

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with Smoking Cessation in 1 studies

alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid: An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies.

Smoking Cessation: Discontinuing the habit of SMOKING.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Khazaal, Y1
Cornuz, J1
Bilancioni, R1
Zullino, DF1

Trials

1 trial available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Smoking Cessation

ArticleYear
Topiramate for smoking cessation.
    Psychiatry and clinical neurosciences, 2006, Volume: 60, Issue:3

    Topics: Adult; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Behavior, Addictive; Female; Fructo

2006